Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v24.i26.2818 http://scihub22266oqcxt.onion/10.3748/wjg.v24.i26.2818 C6048430!6048430!30018477     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=30018477&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Gastroenterol 2018 ; 24 (26): 2818-32 Nephropedia Template TP {{tp|p=30018477|t=2018. Biomarkers of gastric cancer: Current topics and future perspective |pdf=|usr=}}{{30018477}} gab.com Text Biomarkers of gastric cancer: Current topics and future perspective JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=30018477 #FOAvip Gastric cancer (GC) is one of the most prevalent malignant types in the world and an aggressive disease with a poor 5-year survival. This cancer is biologically and genetically heterogeneous with a poorly understood carcinogenesis at the molecular level. Although the incidence is declining, the outcome of patients with GC remains dismal. Thus, the detection at an early stage utilizing useful screening approaches, selection of an appropriate treatment plan, and effective monitoring is pivotal to reduce GC mortalities. Identification of biomarkers in a basis of clinical information and comprehensive genome analysis could improve diagnosis, prognosis, prediction of recurrence and treatment response. This review summarized the current status and approaches in GC biomarker, which could be potentially used for early diagnosis, accurate prediction of therapeutic approaches and discussed the future perspective based on the molecular classification and profiling. Twit Text FOAVip Biomarkers of gastric cancer: Current topics and future perspective ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=30018477 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30018477 #FOAvip English Wikipedia <ref>{{Cite pmid|30018477}}</ref> Biomarkers of gastric cancer: Current topics and future perspective #MMPMID30018477 Matsuoka T; Yashiro M World J Gastroenterol 2018[Jul]; 24 (26): 2818-32 PMID30018477show ga Gastric cancer (GC) is one of the most prevalent malignant types in the world and an aggressive disease with a poor 5-year survival. This cancer is biologically and genetically heterogeneous with a poorly understood carcinogenesis at the molecular level. Although the incidence is declining, the outcome of patients with GC remains dismal. Thus, the detection at an early stage utilizing useful screening approaches, selection of an appropriate treatment plan, and effective monitoring is pivotal to reduce GC mortalities. Identification of biomarkers in a basis of clinical information and comprehensive genome analysis could improve diagnosis, prognosis, prediction of recurrence and treatment response. This review summarized the current status and approaches in GC biomarker, which could be potentially used for early diagnosis, accurate prediction of therapeutic approaches and discussed the future perspective based on the molecular classification and profiling. äBiomarkers of gastric cancer: Current topics and future perspective (epmc).pdf DeepDyve Pubget Overpricing